Bank Julius Baer & Co’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Buy |
21,844
+20,324
| +1,337% | +$5.24M | 0.02% | 235 |
|
|
2025
Q1 | $384K | Buy |
1,520
+460
| +43% | +$116K | ﹤0.01% | 389 |
|
|
2024
Q4 | $267K | Buy |
+1,060
| New | +$267K | ﹤0.01% | 400 |
|
|
2023
Q4 | – | Sell |
-961
| Closed | -$142K | – | 567 |
|
|
2023
Q3 | $142K | Sell |
961
-60
| -6% | -$8.87K | ﹤0.01% | 402 |
|
|
2023
Q2 | $223K | Sell |
1,021
-689
| -40% | -$150K | ﹤0.01% | 399 |
|
|
2023
Q1 | $374K | Sell |
1,710
-437
| -20% | -$95.6K | ﹤0.01% | 377 |
|
|
2022
Q4 | $447K | Buy |
2,147
+164
| +8% | +$34.1K | ﹤0.01% | 352 |
|
|
2022
Q3 | $433K | Buy |
1,983
+1,313
| +196% | +$287K | ﹤0.01% | 344 |
|
|
2022
Q2 | $140K | Sell |
670
-5
| -0.7% | -$1.05K | ﹤0.01% | 452 |
|
|
2022
Q1 | $164K | Buy |
675
+5
| +0.7% | +$1.22K | ﹤0.01% | 441 |
|
|
2021
Q4 | $175K | Hold |
670
| – | – | ﹤0.01% | 538 |
|
|
2021
Q3 | $177K | Buy |
670
+1
| +0.1% | +$264 | ﹤0.01% | 556 |
|
|
2021
Q2 | $165K | Sell |
669
-1,967
| -75% | -$485K | ﹤0.01% | 593 |
|
|
2021
Q1 | $511K | Buy |
2,636
+1,968
| +295% | +$382K | ﹤0.01% | 442 |
|
|
2020
Q4 | $142K | Sell |
668
-322
| -33% | -$68.4K | ﹤0.01% | 603 |
|
|
2020
Q3 | $170K | Hold |
990
| – | – | ﹤0.01% | 530 |
|
|
2020
Q2 | $190K | Sell |
990
-2,288
| -70% | -$439K | ﹤0.01% | 473 |
|
|
2020
Q1 | $483K | Buy |
+3,278
| New | +$483K | 0.01% | 316 |
|